EUVIMEDEUVIMED entdecken
Crossref

Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data

Yining Zeng, Hao Wu, Xiyue Tan, Ruixia Wang, Yuxia Liu, Xueting Wang, Junguo Duan

Journal of Affective Disorders · 2026-08 · 406 · 121685

DOI: 10.1016/j.jad.2026.121685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-08. Verfasst von Yining Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye School of Chengdu University of TCM, Chengdu, 610072, Sichuan Province, China. Hauptthemen laut MEDLINE: Lithium Carbonate, Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Bipolar Disorder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Lithium carbonate is a classic mood stabilizer for bipolar disorder, yet real-world pharmacovigilance of its safety signals (especially underrecognized systems/populations) is lacking. This study detected disproportional ADR signals via FAERS to clarify its multi-system safety profile and gender/age-specific patterns. METHODS: FAERS data (Q1 2004-Q3 2025) for lithium carbonate as the primary suspected drug were extracted. Duplicate reports were processed per FDA guidelines; ADRs were coded by MedDRA (PTs/SOCs). Disproportionality analysis used ROR, PRR, BCPNN and EBGM algorithms, with N ≥ 10 threshold and Bonferroni correction for false positive reduction. Sensitivity (excluding concomitant medications) and subgroup (gender: male/female; age: 12-20/>20 years) analyses were conducted. RESULTS: 3769 reports (16,976 events) involved 27 SOCs, with Nervous (n = 3072) and Psychiatric (n = 2194) disorders top-ranked. Strong signals included Renal/urinary (ROR = 4.25) and Endocrine (ROR = 11.72) disorders; notable Cardiac signals covered nodal rhythm, sinus bradycardia, prolonged QT interval and Brugada syndrome. After rigorous screening, 161 consistent positive PT signals were identified. Top PTs by EBGM: neonatal toxicity (762.20), nephrogenic diabetes insipidus (486.42), parathyroid gland enlargement (425.61). Therapeutic agent toxicity (n = 336) was the most reported, matching lithium carbonate's narrow therapeutic window. Subgroup differences: males had higher tremor/TSH elevation risks; females, nephrogenic diabetes insipidus/hypercalcemia; adolescents, more thyroid disorders; adults, higher multi-agent toxicity. CONCLUSION: Key ADR signals focus on the nervous, psychiatric, renal-urinary, endocrine and cardiac systems, with distinct gender/age-specific patterns. Clinicians should control dosage, monitor serum lithium/organ function (electrocardiography) and individualize assessments for high-risk groups. This study provides real-world pharmacovigilance evidence for safe lithium carbonate use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lithium CarbonatePharmacovigilanceAdverse Drug Reaction Reporting SystemsBipolar DisorderAntimanic AgentsHumansMaleFemaleAdultAdolescentMiddle AgedYoung AdultChildAged

Stichwörter der Autor:innen

Adverse drug reactionDisproportionality analysisFAERSLithium carbonateMood stabilizerPharmacovigilance

Substanzen

Lithium CarbonateAntimanic Agents

Autor:innen und Institutionen

  • Eye School of Chengdu University of TCM, Chengdu, 610072, Sichuan Province, China.
  • Ineye Hospital of Chengdu University of TCM, Chengdu, 610084, Sichuan Province, China; Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection with TCM Laboratory, Chengdu, 610…

Förderung

  • Science and Technology Department of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Zeng, Y., Wu, H., Tan, X., Wang, R., Liu, Y., Wang, X., & Duan, J. (2026). Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data. Journal of Affective Disorders, 406, 121685. https://doi.org/10.1016/j.jad.2026.121685

Vancouver

Zeng Y, Wu H, Tan X, Wang R, Liu Y, Wang X, et al. Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data. Journal of Affective Disorders. 2026;406:121685. doi:10.1016/j.jad.2026.121685

BibTeX
@article{Zeng2026,
  author = {Zeng, Yining and Wu, Hao and Tan, Xiyue and Wang, Ruixia and Liu, Yuxia and Wang, Xueting and Duan, Junguo},
  title = {Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {406},
  pages = {121685},
  doi = {10.1016/j.jad.2026.121685}
}
Kostenlos starten →